Fibristal (ulipristal acetate)

pCPA File Number: 21077

Negotiation Status:

Concluded with an LOI

Indication(s):

Intermittent treatment of moderate to severe signs and symptoms of uterine fibroids
uterine fibroids

Sponsor/Manufacturer:

Allergan Inc.

CADTH Project Number:

SF0528-000

pCPA Engagement Letter Issued:

2018-09-28

Negotiation Process Concluded:

2019-08-06